CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) Dividend History

CASI Pharmaceuticals, Inc. is a biotechnology company focused on the development and commercialization of innovative treatments for cancer, infectious diseases, and other serious conditions. Founded in 2009 and headquartered in Rockville, Maryland, CASI aims to leverage its expertise in drug repurposing and development through strategic collaborations and regulatory approvals, primarily in China and other international markets. The company focuses on bringing both innovative and re-purposed therapies to underserved patient populations worldwide.

Dividend History

CASI Pharmaceuticals, Inc. Ordinary Shares currently does not pay dividends

Company News

  • CASI Pharmaceuticals (CASI) gets a proposal letter from its chairman for acquiring its business operations in China. Its shares rise on the news.

    Zacks Investment Research
    Featured Companies: ALXO ANVS CGEN
  • HC Wainwright & Co. has decided to maintain its Buy rating of CASI Pharmaceuticals (NASDAQ:CASI) and raise its price target from $10.00 to $12.00. Shares of CASI Pharmaceuticals are trading up 1.33% over the last 24 hours, at $4.56 per share. A move to $12.00 would account for a 163.16% increase from the current share price. About CASI Pharmaceuticals CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. ...Full story available on Benzinga.com

    Benzinga
  • Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: EYEG
Page data last updated 07/25/2025 01:12:48 UTC